BLTE

$0.00

(

0.00%

)
Quote details

stock

Belite Bio Inc ADR

NASDAQ | BLTE

66.26

USD

$0.00

(

0.00%

)

At Close (As of Sep 16, 2025)

$2.28B

Market Cap

-

P/E Ratio

-1.55

EPS

$86.53

52 Week High

$43.70

52 Week Low

HEALTHCARE

Sector

BLTE Chart

Recent Chart
Price Action

BLTE Technicals

Tags:

BLTE Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$449K
Total Revenue $0
Cost Of Revenue $449K
Costof Goods And Services Sold $449K
Operating Income -$40M
Selling General And Administrative $10M
Research And Development $30M
Operating Expenses $40M
Investment Income Net -
Net Interest Income $3.7M
Interest Income $3.7M
Interest Expense $20K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $449K
Income Before Tax -$36M
Income Tax Expense $6K
Interest And Debt Expense -
Net Income From Continuing Operations -$36M
Comprehensive Income Net Of Tax -
Ebit -$36M
Ebitda -$36M
Net Income -$36M

Revenue & Profitability

Earnings Performance

BLTE Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $152M
Total Current Assets $147M
Cash And Cash Equivalents At Carrying Value $32M
Cash And Short Term Investments $32M
Inventory -
Current Net Receivables $594K
Total Non Current Assets $5.1M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $4M
Intangible Assets Excluding Goodwill $4M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $113M
Other Current Assets $1.3M
Other Non Current Assets -
Total Liabilities $6.3M
Total Current Liabilities $6.1M
Current Accounts Payable -
Deferred Revenue -
Current Debt -
Short Term Debt $276K
Total Non Current Liabilities $261K
Capital Lease Obligations $537K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $537K
Other Current Liabilities $5.8M
Other Non Current Liabilities -
Total Shareholder Equity $146M
Treasury Stock -
Retained Earnings -$108M
Common Stock $3K
Common Stock Shares Outstanding $31M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$29M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $449K
Capital Expenditures $151K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$111M
Cashflow From Financing $84M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$36M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$449K
Total Revenue $0
Cost Of Revenue $449K
Costof Goods And Services Sold $449K
Operating Income -$40M
Selling General And Administrative $10M
Research And Development $30M
Operating Expenses $40M
Investment Income Net -
Net Interest Income $3.7M
Interest Income $3.7M
Interest Expense $20K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $449K
Income Before Tax -$36M
Income Tax Expense $6K
Interest And Debt Expense -
Net Income From Continuing Operations -$36M
Comprehensive Income Net Of Tax -
Ebit -$36M
Ebitda -$36M
Net Income -$36M

BLTE News

BLTE Profile

Belite Bio Inc ADR Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, is engaged in the research and development of novel therapies targeting age-related atrophic macular degeneration and autosomal recessive stargardt diseases. The company is headquartered in San Diego, California.

ADAP
+24.02%
$0.08
CGBS
-39.47%
$0.03
CODX
+53.56%
$0.54
TSLA
+3.56%
$410.04
MULN
+9.26%
$0.07
TURB
+433.70%
$14.41
KDLY
-55.39%
$1.24
APVO
+11.07%
$1.59
BITF
+13.10%
$2.80
SNAP
+1.20%
$7.55
GRAB
+3.17%
$6.33
TPIC
-45.91%
$0.12
NVDA
-1.52%
$175.03
AXDX
-61.36%
$0.03
NIO
+6.14%
$6.88
OPI
-1.88%
$0.86
AAL
-0.87%
$12.42
NAKA
+23.79%
$1.53
MARA
+6.37%
$17.27
SLNH
+9.30%
$1.01
WBD
-7.07%
$18.08
LYT
-16.77%
$0.09
BGI
+55.64%
$1.32
AIHS
+17.67%
$2.52
SOFI
-2.07%
$27.09
SOUN
-0.03%
$14.18
DNN
-3.48%
$2.49
RMBL
+60.50%
$3.21
FGI
+137.27%
$9.42
CNFR
+41.83%
$1.60
ATCH
-8.91%
$0.90
ADD
-25.47%
$0.05
RAYA
+1.26%
$0.04
SRM
+53.27%
$10.30
ATYR
+7.38%
$1.09
BINI
-9.13%
$0.06
AAPL
+1.08%
$239.27
RIVN
+6.43%
$14.47
PLUG
+4.17%
$1.63
ORCL
+0.38%
$303.30
INTC
+1.03%
$25.02
BTG
-1.02%
$4.34
HIMS
-6.56%
$50.42
BTE
+10.35%
$2.60
RKLB
-11.75%
$47.68
NWTN
+3.42%
$1.51
JOBY
-1.06%
$13.97
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
F
-1.08%
$11.55
WLGS
-5.57%
$0.04
AIIO
+30.54%
$1.97
QS
-2.94%
$10.05
RR
-0.38%
$3.87
LPSN
-23.63%
$0.67
TLRY
+1.42%
$1.19
NFE
+21.53%
$1.67
ETWO
0.00%
$3.30
ORIS
-23.80%
$0.13
RZLV
-1.79%
$7.58
ITUB
+0.14%
$7.15
CJET
-24.62%
$0.08
AMZN
+1.46%
$234.83
VALE
+0.23%
$10.85
ONDS
-4.70%
$6.08
AFMD
-34.94%
$0.18
CAN
-3.65%
$0.78
RGTI
+1.01%
$19.40
PLTR
-0.71%
$169.98
FAAS
-25.13%
$0.09
QBTS
+1.74%
$18.64
IREN
-0.86%
$36.81
CLSK
-0.57%
$10.29
RIOT
+3.03%
$17.18
ABEV
+1.28%
$2.36
BMNR
-1.62%
$52.24
PFE
-0.16%
$23.93
IMTE
-3.69%
$1.04
ACHR
+0.10%
$9.13
HOOD
+2.00%
$117.12
CRWV
-3.58%
$116.15
GRYP
-10.38%
$1.38
BBD
+0.62%
$3.20
GOOGL
+0.20%
$252.12
MODV
-25.22%
$0.43
CIFR
+4.80%
$11.37
KEY
-1.58%
$18.54
OSCR
-3.27%
$18.11
QUBT
-4.45%
$16.08
JD
+2.95%
$34.61
NUKK
+18.85%
$6.12
BURU
-6.27%
$0.14
NOK
+0.21%
$4.55
CSCO
+0.73%
$67.02
RIG
+3.17%
$3.41
IXHL
-0.20%
$0.52
AMD
-0.76%
$159.93
GPUS
-13.96%
$0.38
CHEK
+14.15%
$2.42
HBAN
-1.36%
$17.39
ADAP
+24.02%
$0.08
CGBS
-39.47%
$0.03
CODX
+53.56%
$0.54
TSLA
+3.56%
$410.04
MULN
+9.26%
$0.07
TURB
+433.70%
$14.41
KDLY
-55.39%
$1.24
APVO
+11.07%
$1.59
BITF
+13.10%
$2.80
SNAP
+1.20%
$7.55
GRAB
+3.17%
$6.33
TPIC
-45.91%
$0.12
NVDA
-1.52%
$175.03
AXDX
-61.36%
$0.03
NIO
+6.14%
$6.88
OPI
-1.88%
$0.86
AAL
-0.87%
$12.42
NAKA
+23.79%
$1.53
MARA
+6.37%
$17.27
SLNH
+9.30%
$1.01
WBD
-7.07%
$18.08
LYT
-16.77%
$0.09
BGI
+55.64%
$1.32
AIHS
+17.67%
$2.52
SOFI
-2.07%
$27.09
SOUN
-0.03%
$14.18
DNN
-3.48%
$2.49
RMBL
+60.50%
$3.21
FGI
+137.27%
$9.42
CNFR
+41.83%
$1.60
ATCH
-8.91%
$0.90
ADD
-25.47%
$0.05
RAYA
+1.26%
$0.04
SRM
+53.27%
$10.30
ATYR
+7.38%
$1.09
BINI
-9.13%
$0.06
AAPL
+1.08%
$239.27
RIVN
+6.43%
$14.47
PLUG
+4.17%
$1.63
ORCL
+0.38%
$303.30
INTC
+1.03%
$25.02
BTG
-1.02%
$4.34
HIMS
-6.56%
$50.42
BTE
+10.35%
$2.60
RKLB
-11.75%
$47.68
NWTN
+3.42%
$1.51
JOBY
-1.06%
$13.97
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
F
-1.08%
$11.55
WLGS
-5.57%
$0.04
AIIO
+30.54%
$1.97
QS
-2.94%
$10.05
RR
-0.38%
$3.87
LPSN
-23.63%
$0.67
TLRY
+1.42%
$1.19
NFE
+21.53%
$1.67
ETWO
0.00%
$3.30
ORIS
-23.80%
$0.13
RZLV
-1.79%
$7.58
ITUB
+0.14%
$7.15
CJET
-24.62%
$0.08
AMZN
+1.46%
$234.83
VALE
+0.23%
$10.85
ONDS
-4.70%
$6.08
AFMD
-34.94%
$0.18
CAN
-3.65%
$0.78
RGTI
+1.01%
$19.40
PLTR
-0.71%
$169.98
FAAS
-25.13%
$0.09
QBTS
+1.74%
$18.64
IREN
-0.86%
$36.81
CLSK
-0.57%
$10.29
RIOT
+3.03%
$17.18
ABEV
+1.28%
$2.36
BMNR
-1.62%
$52.24
PFE
-0.16%
$23.93
IMTE
-3.69%
$1.04
ACHR
+0.10%
$9.13
HOOD
+2.00%
$117.12
CRWV
-3.58%
$116.15
GRYP
-10.38%
$1.38
BBD
+0.62%
$3.20
GOOGL
+0.20%
$252.12
MODV
-25.22%
$0.43
CIFR
+4.80%
$11.37
KEY
-1.58%
$18.54
OSCR
-3.27%
$18.11
QUBT
-4.45%
$16.08
JD
+2.95%
$34.61
NUKK
+18.85%
$6.12
BURU
-6.27%
$0.14
NOK
+0.21%
$4.55
CSCO
+0.73%
$67.02
RIG
+3.17%
$3.41
IXHL
-0.20%
$0.52
AMD
-0.76%
$159.93
GPUS
-13.96%
$0.38
CHEK
+14.15%
$2.42
HBAN
-1.36%
$17.39

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.